Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment

A randomized trial (VITACOG) in people with mild cognitive impairment (MCI) found that B vitamin treatment to lower homocysteine slowed the rate of cognitive and clinical decline. We have used data from this trial to see whether baseline omega-3 fatty acid status interacts with the effects of B vita...

Descripción completa

Detalles Bibliográficos
Autores principales: Oulhaj, Abderrahim, Jernerén, Fredrik, Refsum, Helga, Smith, A. David, de Jager, Celeste A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927899/
https://www.ncbi.nlm.nih.gov/pubmed/26757190
http://dx.doi.org/10.3233/JAD-150777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927899/
https://www.ncbi.nlm.nih.gov/pubmed/26757190
http://dx.doi.org/10.3233/JAD-150777

Ejemplares similares